About Docetaxel (Anhydrous)
Class: | Antineoplastic agent, Taxane derivative
Use: | Docetaxel (Anhydrous) is used for the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Adult dose: | The standard adult dosing for Docetaxel varies based on the type of cancer being treated and the patient's condition. Typically, it is administered as an intravenous infusion at a dose of 75-100 mg/m² every 3 weeks, often in combination wit
Drug Class
Antineoplastic agent, Taxane derivative
Uses & Indications
Docetaxel (Anhydrous) is used for the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Storage Requirements
Store Docetaxel at controlled room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and do not freeze. Once diluted for infusion, it should be used within the time frame specified by the manufacturer, typically within 4 hours if stored at room temperature.
Manufacturer & Packaging
Manufacturer: Aventis Pharma, UNITED KINGDOM
Package Size
0.5ml Vial + 1.83ml Solvent Vial
Price & Supplier
Price in UAE: AED 941.00
Dosage Information
Adult Dose
The standard adult dosing for Docetaxel varies based on the type of cancer being treated and the patient's condition. Typically, it is administered as an intravenous infusion at a dose of 75-100 mg/m² every 3 weeks, often in combination with other chemotherapy agents. Dose adjustments may be necessary based on patient tolerance and response.
Pediatric Dose
The safety and efficacy of Docetaxel in pediatric patients have not been established. Therefore, it is not typically used in pediatric populations.
Side Effects
Common side effects include neutropenia, anemia, fluid retention, alopecia, nausea, vomiting, diarrhea, fatigue, and peripheral neuropathy. Patients may also experience hypersensitivity reactions.
Contraindications & Precautions
Docetaxel is contraindicated in patients with a known hypersensitivity to docetaxel or polysorbate 80, and in patients with baseline neutrophil counts <1500 cells/mm³. It should be used with caution in patients with hepatic impairment.
Important Warnings
Important safety warnings include the risk of severe hypersensitivity reactions, fluid retention, and myelosuppression. Patients should be premedicated with corticosteroids to reduce the risk of hypersensitivity and fluid retention. Regular monitoring of blood counts is essential to manage myelosuppression. Use caution in patients with hepatic impairment, as they are at increased risk of toxicity.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.